Replimune Group Inc — Balance Sheet (NASDAQ:REPL) | MetaTrader

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Total assets 543.1 M461.19 M646.59 M487.72 M551.33 M Total liabilities 44.37 M49.96 M91.3 M113.21 M135.49 M Total equity 498.73 M411.23 M555.29 M374.51 M415.84 M Total liabilities & shareholders' equities 543.1 M461.19 M646.59 M487.72 M551.33 M Total debt ————— Net debt —————

Новости

Replimune Stock: Multiple Shots On Goal But A High Risk Binary Approaches (NASDAQ:REPL)

Wall Street Analysts Predict a 65.72% Upside in Replimune Group (REPL): Here's What You Should Know

Here's Why Replimune Stock Skyrockets Nearly 131% in 3 Months

Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)

Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3

The Short List — Top 10 Most Shorted Stocks Right Now - Lucid Group (NASDAQ:LCID)

Iovance Biotherapeutics: Several Positives, But Competition Still Threatens (NASDAQ:IOVA)

Cantor Fitzgerald подтверждает рейтинг Overweight для акций Replimune

Cantor Fitzgerald reiterates Overweight rating on Replimune Group stock

Replimune сообщает положительные данные по лечению меланомы на SITC 2025

Replimune reports positive data for melanoma treatment at SITC 2025

Kimberly-Clark, Vertex And Other Big Stocks Moving Lower In Monday's Pre-Market Session - ALPS Group (NASDAQ:ALPS), Alvotech (NASDAQ:ALVO)